NOVAVAX INC — Director's Dealing 2014

Mar 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-03-06

Reporting Person: Erck Stanley C (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-06	Stock Option (Right to buy)	$6.05	A	900000	Acquired	2024-03-06	Common Stock (900000)	Direct

Footnotes

F1: This option grant was approved by Novavax's board of directors on March 6, 2014.

F2: The option vests in four equal annual installments beginning on the first anniversary of the date of grant.